Global Age Related Macular Degeneration (AMD) Market Size, Share & Industry Trends Analysis Report By Drug Type (Aflibercept, Ranibizumab and Others), By Disease Type (Wet and Dry), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030

The Global Age Related Macular Degeneration (AMD) Market size is expected to reach $13.9 billion by 2030, rising at a market growth of 5.4% CAGR during the forecast period.

The steep rise in per-capita healthcare spending, in addition to the rising public demand for high- quality, inexpensive healthcare services, is driving the growth of healthcare products, therefore, hospital pharmacy would generate more than 55% share of the market by 2030. The increasing number & size of investments invested in the healthcare industry by governments of different nations is one of the primary drivers of the market’s growth. The WHO reports that healthcare spending reached a record high of US $9 trillion (about 11% of global GDP) due to substantial increases in healthcare spending by governments at all income levels. In general, rising government health spending largely offsets declining personal spending. Increasing spending in the healthcare industry has led to an increase in market innovations. Some of the factors impacting the market are increase in elderly population, growing awareness of AMD, and Wet AMD drugs' adverse effects.

As it gets worse with time, vision loss in the elderly is a major issue. The two main types of macula deterioration are wet and dry macular degeneration. Both are possibly fatal and require medical care. According to the WHO, there will be 1.4 billion people aged 60 and older by 2050, up from the current 1 billion. The number of individuals 60 and older worldwide will double (to 2.1 billion) by 2050. Some key players are working on vitreous implants and longer-acting anti-VEGFs that enable sustained medication delivery. Additionally, the most frequent cause of permanent vision loss is macular degeneration. To make the public aware of the effects of AMD and the best treatment options, NGOs, optometrist groups, and health agencies run various programs, activities, and campaigns. The National AMD Awareness Month celebrated in February and strives to increase awareness of AMD as the main cause of visual loss, is one such significant initiative. Rising financing for the condition's research and related activities, which also encourage people to have eye exams to improve the likelihood of early identification, is another factor driving the need for macular degeneration drugs.

However, wet AMD medicines' wide range of negative effects constrains the market's growth. Growth is expected to be restricted by side effects such as retinal vasculitis, intraocular inflammation, concomitant vascular occlusion, nausea, vomiting, stopping loss of vision in 90% of cases, bleeding in the eye, redness & irritation of the eye, and individuals losing their vision permanently. High blood pressure and inflammation of the nose and throat are also prevalent. Furthermore, these medications are injected directly into the eye, which carries potential hazards. These issues may hamper market expansion. Moreover, as the COVID-19 pandemic had significant effects on healthcare systems globally, including the treatment and management of chronic diseases like age-related macular degeneration (AMD), it had a negative impact on the age-related degeneration (AMD) market. Due to clinic closures and reduced hospital capacity during the outbreak, many people could not get basic eye care and treatment. However, the pandemic impacted the development and approval of new treatments for age-related macular degeneration (AMD), which has had a negative effect on the expanding AMD market.

Drug Type Outlook

On the basis of drug type, the market is segmented into aflibercept, ranibizumab, and others. In 2022, the aflibercept segment dominated the market with the maximum revenue share. This segment will expand due to the increased use of the medicine Aflibercept globally and the rise in age-related macular degeneration (AMD) among the older population.

Disease Type Outlook

Based on diseases type, the market is classified into wet, and dry. The dry segment garnered a significant revenue share in the market in 2022. Dry AMD causes 85 to 90% of all cases of macular degeneration. Vitamin formulations are the only treatment options for dry macular degeneration. Luminate, Zimura, and intravitreal pegcetacoplan are only a few of the cutting-edge therapeutic approaches for its treatment that are now being tested in clinical settings. Accepting these candidates could accelerate the dry AMD segment's expansion in the upcoming years.

Distribution Channel Outlook

By distribution channel, the market is categorized into hospital pharmacy, retail pharmacy, and online pharmacy. The online segment recorded a remarkable revenue share in the market in 2022. The segment's growth is primarily driven by rising internet usage, the digitization of healthcare services, and an increase in tech-savvy consumers worldwide. Consumers' desire for online shopping, which is increasingly centered on convenience, is also a factor in the increase.

Age Related Macular Degeneration (AMD) Market Report Coverage

Report Attribute	Details
Market size value in 2022	USD 9.2 Billion
Market size forecast in 2030	USD 13.9 Billion
Base Year	2022
Historical Period	2019 to 2021
Forecast Period	2023 to 2030
Revenue Growth Rate	CAGR of 5.4% from 2023 to 2030
Number of Pages	242
Number of Table	340
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling
Segments covered	Drug Type, Disease Type, Distribution Channel, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Increase in elderly population fuels cases of age-related eye disease Rising healthcare expenditure and government support
Restraints	Wet AMD drugs' adverse effects

Regional Outlook

Region wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific region covered a considerable revenue share in the market in 2022. The sale of medications for exudative AMD is now very low in APAC because of problems with accessibility and expensive prescriptions. However, AMD is highly prevalent in this region, making it a potentially growing market. A few companies in APAC are also involved in the marketing and research of exudative AMD therapies. In addition, the demand for wet age-related macular degeneration drugs is expected to rise considerably in the coming years due to the region accounting for more than a third of all age-related macular degeneration cases globally.

Free Valuable Insights: Global Age Related Macular Degeneration (AMD) Market size to reach USD 13.9 Billion by 2030

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Biogen, Inc., Bayer AG, Apellis Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., Ionis Pharmaceuticals, Inc., Novartis AG, Sanofi S.A., Coherus Biosciences, Inc. and Bausch Health Companies, Inc.

Strategies deployed in the Market

• Jun-2023: Bausch + Lomb introduced PreserVision AREDS 2 Formula soft gels plus coenzyme Q10 (CoQ10) in the United States. It is the only eye vitamin that combines the precise nutrient formula advised by the National Eye Institute (NEI) to help reduce the risk of moderate to advanced Age-related Macular Degeneration (AMD) progression in AMD patients with CoQ10 to support heart health.
• Feb-2023: Apellis Pharmaceuticals received approval from the U.S. Food & Drug Administration (FDA) for SYFOVRE™ (pegcetacoplan injection). This injection is launched for people with geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
• Aug-2022: Coherus BioSciences announced that the U.S. Food and Drug Administration (FDA) approved CIMERLITM (ranibizumab-eqrn) as a biosimilar product interchangeable with Lucentis® (ranibizumab injection) for all five indications. This product satisfies all of the FDA's strict requirements for the reference product, including those for quality, safety, and efficacy. The anti-VEGF therapeutic class of biologics, which includes CIMERLITM, has revolutionized how retinal patients can keep or regain eyesight.
• Jun-2022: Biogen together with Samsung Bioepis Co., Ltd. launched BYOOVIZ™ (ranibizumab-nuna), a biosimilar referencing LUCENTIS® (ranibizumab)i in the United States. The biosimilar has been approved by FDA and it would be utilized for the treatment of macular edema following retinal vein occlusion, neovascular (wet) age-related macular degeneration (AMD), and myopic choroidal neovascularization. This is an affordable treatment option for patients suffering from retinal vascular disorders.
• Feb-2022: Novartis completed the acquisition of Gyroscope Therapeutics, a clinical-stage gene therapy company. With this acquisition, Novartis would take another step toward its goal of providing ophthalmic innovation to treat and prevent blindness globally. The acquisition strengthened its current expertise in retinal disorders and gene therapy.
• Oct-2020: Novartis took over Vedere Bio, a growing pharmaceutical company. The acquisition strengthened Novartis' dedication to cell and gene therapy and helped Novartis accelerate its efforts to provide revolutionary treatments to a variety of patients with blinding conditions. Additionally, the acquisition increased Novartis' presence in ophthalmology and strengthened its position as a global leader in AAV-based gene therapy.
• Oct-2019: Novartis got the U.S. Food and Drug Administration approval for Beovu® (brolucizumab) injection, also known as RTH258. This injection would be utilized in the treatment of wet age-related macular degeneration (AMD). Beovu is the only anti-VEGF licensed by the FDA to provide both better fluid resolution compared to aflibercept and the capacity to keep eligible wet AMD patients on a three-month dosage interval immediately following a three-month loading phase with uncompromised efficacy.

Scope of the Study

Market Segments Covered in the Report:

By Drug Type

• Aflibercept
• Ranibizumab
• Others

By Disease Type

• Wet
• Dry

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Biogen, Inc.
• Bayer AG
• Apellis Pharmaceuticals, Inc.
• Regeneron Pharmaceuticals, Inc.
• F.Hoffmann-La Roche Ltd.
• Ionis Pharmaceuticals, Inc.
• Novartis AG
• Sanofi S.A.
• Coherus Biosciences, Inc.
• Bausch Health Companies, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Age Related Macular Degeneration (AMD) Market, by Drug Type
1.4.2 Global Age Related Macular Degeneration (AMD) Market, by Disease Type
1.4.3 Global Age Related Macular Degeneration (AMD) Market, by Distribution Channel
1.4.4 Global Age Related Macular Degeneration (AMD) Market, by Geography
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis

Chapter 4. Strategies deployed in Age Related Macular Degeneration (AMD) Market

Chapter 5. Global Age Related Macular Degeneration (AMD) Market by Drug Type
5.1 Global Aflibercept Market by Region
5.2 Global Ranibizumab Market by Region
5.3 Global Others Market by Region

Chapter 6. Global Age Related Macular Degeneration (AMD) Market by Disease Type
6.1 Global Wet Market by Region
6.2 Global Dry Market by Region

Chapter 7. Global Age Related Macular Degeneration (AMD) Market by Distribution Channel
7.1 Global Hospital Pharmacy Market by Region
7.2 Global Retail Pharmacy Market by Region
7.3 Global Online Pharmacy Market by Region

Chapter 8. Global Age Related Macular Degeneration (AMD) Market by Region
8.1 North America Age Related Macular Degeneration (AMD) Market
8.1.1 North America Age Related Macular Degeneration (AMD) Market by Drug Type
8.1.1.1 North America Aflibercept Market by Country
8.1.1.2 North America Ranibizumab Market by Country
8.1.1.3 North America Others Market by Country
8.1.2 North America Age Related Macular Degeneration (AMD) Market by Disease Type
8.1.2.1 North America Wet Market by Country
8.1.2.2 North America Dry Market by Country
8.1.3 North America Age Related Macular Degeneration (AMD) Market by Distribution Channel
8.1.3.1 North America Hospital Pharmacy Market by Country
8.1.3.2 North America Retail Pharmacy Market by Country
8.1.3.3 North America Online Pharmacy Market by Country
8.1.4 North America Age Related Macular Degeneration (AMD) Market by Country
8.1.4.1 US Age Related Macular Degeneration (AMD) Market
8.1.4.1.1 US Age Related Macular Degeneration (AMD) Market by Drug Type
8.1.4.1.2 US Age Related Macular Degeneration (AMD) Market by Disease Type
8.1.4.1.3 US Age Related Macular Degeneration (AMD) Market by Distribution Channel
8.1.4.2 Canada Age Related Macular Degeneration (AMD) Market
8.1.4.2.1 Canada Age Related Macular Degeneration (AMD) Market by Drug Type
8.1.4.2.2 Canada Age Related Macular Degeneration (AMD) Market by Disease Type
8.1.4.2.3 Canada Age Related Macular Degeneration (AMD) Market by Distribution Channel
8.1.4.3 Mexico Age Related Macular Degeneration (AMD) Market
8.1.4.3.1 Mexico Age Related Macular Degeneration (AMD) Market by Drug Type
8.1.4.3.2 Mexico Age Related Macular Degeneration (AMD) Market by Disease Type
8.1.4.3.3 Mexico Age Related Macular Degeneration (AMD) Market by Distribution Channel
8.1.4.4 Rest of North America Age Related Macular Degeneration (AMD) Market
8.1.4.4.1 Rest of North America Age Related Macular Degeneration (AMD) Market by Drug Type
8.1.4.4.2 Rest of North America Age Related Macular Degeneration (AMD) Market by Disease Type
8.1.4.4.3 Rest of North America Age Related Macular Degeneration (AMD) Market by Distribution Channel
8.2 Europe Age Related Macular Degeneration (AMD) Market
8.2.1 Europe Age Related Macular Degeneration (AMD) Market by Drug Type
8.2.1.1 Europe Aflibercept Market by Country
8.2.1.2 Europe Ranibizumab Market by Country
8.2.1.3 Europe Others Market by Country
8.2.2 Europe Age Related Macular Degeneration (AMD) Market by Disease Type
8.2.2.1 Europe Wet Market by Country
8.2.2.2 Europe Dry Market by Country
8.2.3 Europe Age Related Macular Degeneration (AMD) Market by Distribution Channel
8.2.3.1 Europe Hospital Pharmacy Market by Country
8.2.3.2 Europe Retail Pharmacy Market by Country
8.2.3.3 Europe Online Pharmacy Market by Country
8.2.4 Europe Age Related Macular Degeneration (AMD) Market by Country
8.2.4.1 Germany Age Related Macular Degeneration (AMD) Market
8.2.4.1.1 Germany Age Related Macular Degeneration (AMD) Market by Drug Type
8.2.4.1.2 Germany Age Related Macular Degeneration (AMD) Market by Disease Type
8.2.4.1.3 Germany Age Related Macular Degeneration (AMD) Market by Distribution Channel
8.2.4.2 UK Age Related Macular Degeneration (AMD) Market
8.2.4.2.1 UK Age Related Macular Degeneration (AMD) Market by Drug Type
8.2.4.2.2 UK Age Related Macular Degeneration (AMD) Market by Disease Type
8.2.4.2.3 UK Age Related Macular Degeneration (AMD) Market by Distribution Channel
8.2.4.3 France Age Related Macular Degeneration (AMD) Market
8.2.4.3.1 France Age Related Macular Degeneration (AMD) Market by Drug Type
8.2.4.3.2 France Age Related Macular Degeneration (AMD) Market by Disease Type
8.2.4.3.3 France Age Related Macular Degeneration (AMD) Market by Distribution Channel
8.2.4.4 Russia Age Related Macular Degeneration (AMD) Market
8.2.4.4.1 Russia Age Related Macular Degeneration (AMD) Market by Drug Type
8.2.4.4.2 Russia Age Related Macular Degeneration (AMD) Market by Disease Type
8.2.4.4.3 Russia Age Related Macular Degeneration (AMD) Market by Distribution Channel
8.2.4.5 Spain Age Related Macular Degeneration (AMD) Market
8.2.4.5.1 Spain Age Related Macular Degeneration (AMD) Market by Drug Type
8.2.4.5.2 Spain Age Related Macular Degeneration (AMD) Market by Disease Type
8.2.4.5.3 Spain Age Related Macular Degeneration (AMD) Market by Distribution Channel
8.2.4.6 Italy Age Related Macular Degeneration (AMD) Market
8.2.4.6.1 Italy Age Related Macular Degeneration (AMD) Market by Drug Type
8.2.4.6.2 Italy Age Related Macular Degeneration (AMD) Market by Disease Type
8.2.4.6.3 Italy Age Related Macular Degeneration (AMD) Market by Distribution Channel
8.2.4.7 Rest of Europe Age Related Macular Degeneration (AMD) Market
8.2.4.7.1 Rest of Europe Age Related Macular Degeneration (AMD) Market by Drug Type
8.2.4.7.2 Rest of Europe Age Related Macular Degeneration (AMD) Market by Disease Type
8.2.4.7.3 Rest of Europe Age Related Macular Degeneration (AMD) Market by Distribution Channel
8.3 Asia Pacific Age Related Macular Degeneration (AMD) Market
8.3.1 Asia Pacific Age Related Macular Degeneration (AMD) Market by Drug Type
8.3.1.1 Asia Pacific Aflibercept Market by Country
8.3.1.2 Asia Pacific Ranibizumab Market by Country
8.3.1.3 Asia Pacific Others Market by Country
8.3.2 Asia Pacific Age Related Macular Degeneration (AMD) Market by Disease Type
8.3.2.1 Asia Pacific Wet Market by Country
8.3.2.2 Asia Pacific Dry Market by Country
8.3.3 Asia Pacific Age Related Macular Degeneration (AMD) Market by Distribution Channel
8.3.3.1 Asia Pacific Hospital Pharmacy Market by Country
8.3.3.2 Asia Pacific Retail Pharmacy Market by Country
8.3.3.3 Asia Pacific Online Pharmacy Market by Country
8.3.4 Asia Pacific Age Related Macular Degeneration (AMD) Market by Country
8.3.4.1 China Age Related Macular Degeneration (AMD) Market
8.3.4.1.1 China Age Related Macular Degeneration (AMD) Market by Drug Type
8.3.4.1.2 China Age Related Macular Degeneration (AMD) Market by Disease Type
8.3.4.1.3 China Age Related Macular Degeneration (AMD) Market by Distribution Channel
8.3.4.2 Japan Age Related Macular Degeneration (AMD) Market
8.3.4.2.1 Japan Age Related Macular Degeneration (AMD) Market by Drug Type
8.3.4.2.2 Japan Age Related Macular Degeneration (AMD) Market by Disease Type
8.3.4.2.3 Japan Age Related Macular Degeneration (AMD) Market by Distribution Channel
8.3.4.3 India Age Related Macular Degeneration (AMD) Market
8.3.4.3.1 India Age Related Macular Degeneration (AMD) Market by Drug Type
8.3.4.3.2 India Age Related Macular Degeneration (AMD) Market by Disease Type
8.3.4.3.3 India Age Related Macular Degeneration (AMD) Market by Distribution Channel
8.3.4.4 South Korea Age Related Macular Degeneration (AMD) Market
8.3.4.4.1 South Korea Age Related Macular Degeneration (AMD) Market by Drug Type
8.3.4.4.2 South Korea Age Related Macular Degeneration (AMD) Market by Disease Type
8.3.4.4.3 South Korea Age Related Macular Degeneration (AMD) Market by Distribution Channel
8.3.4.5 Singapore Age Related Macular Degeneration (AMD) Market
8.3.4.5.1 Singapore Age Related Macular Degeneration (AMD) Market by Drug Type
8.3.4.5.2 Singapore Age Related Macular Degeneration (AMD) Market by Disease Type
8.3.4.5.3 Singapore Age Related Macular Degeneration (AMD) Market by Distribution Channel
8.3.4.6 Malaysia Age Related Macular Degeneration (AMD) Market
8.3.4.6.1 Malaysia Age Related Macular Degeneration (AMD) Market by Drug Type
8.3.4.6.2 Malaysia Age Related Macular Degeneration (AMD) Market by Disease Type
8.3.4.6.3 Malaysia Age Related Macular Degeneration (AMD) Market by Distribution Channel
8.3.4.7 Rest of Asia Pacific Age Related Macular Degeneration (AMD) Market
8.3.4.7.1 Rest of Asia Pacific Age Related Macular Degeneration (AMD) Market by Drug Type
8.3.4.7.2 Rest of Asia Pacific Age Related Macular Degeneration (AMD) Market by Disease Type
8.3.4.7.3 Rest of Asia Pacific Age Related Macular Degeneration (AMD) Market by Distribution Channel
8.4 LAMEA Age Related Macular Degeneration (AMD) Market
8.4.1 LAMEA Age Related Macular Degeneration (AMD) Market by Drug Type
8.4.1.1 LAMEA Aflibercept Market by Country
8.4.1.2 LAMEA Ranibizumab Market by Country
8.4.1.3 LAMEA Others Market by Country
8.4.2 LAMEA Age Related Macular Degeneration (AMD) Market by Disease Type
8.4.2.1 LAMEA Wet Market by Country
8.4.2.2 LAMEA Dry Market by Country
8.4.3 LAMEA Age Related Macular Degeneration (AMD) Market by Distribution Channel
8.4.3.1 LAMEA Hospital Pharmacy Market by Country
8.4.3.2 LAMEA Retail Pharmacy Market by Country
8.4.3.3 LAMEA Online Pharmacy Market by Country
8.4.4 LAMEA Age Related Macular Degeneration (AMD) Market by Country
8.4.4.1 Brazil Age Related Macular Degeneration (AMD) Market
8.4.4.1.1 Brazil Age Related Macular Degeneration (AMD) Market by Drug Type
8.4.4.1.2 Brazil Age Related Macular Degeneration (AMD) Market by Disease Type
8.4.4.1.3 Brazil Age Related Macular Degeneration (AMD) Market by Distribution Channel
8.4.4.2 Argentina Age Related Macular Degeneration (AMD) Market
8.4.4.2.1 Argentina Age Related Macular Degeneration (AMD) Market by Drug Type
8.4.4.2.2 Argentina Age Related Macular Degeneration (AMD) Market by Disease Type
8.4.4.2.3 Argentina Age Related Macular Degeneration (AMD) Market by Distribution Channel
8.4.4.3 UAE Age Related Macular Degeneration (AMD) Market
8.4.4.3.1 UAE Age Related Macular Degeneration (AMD) Market by Drug Type
8.4.4.3.2 UAE Age Related Macular Degeneration (AMD) Market by Disease Type
8.4.4.3.3 UAE Age Related Macular Degeneration (AMD) Market by Distribution Channel
8.4.4.4 Saudi Arabia Age Related Macular Degeneration (AMD) Market
8.4.4.4.1 Saudi Arabia Age Related Macular Degeneration (AMD) Market by Drug Type
8.4.4.4.2 Saudi Arabia Age Related Macular Degeneration (AMD) Market by Disease Type
8.4.4.4.3 Saudi Arabia Age Related Macular Degeneration (AMD) Market by Distribution Channel
8.4.4.5 South Africa Age Related Macular Degeneration (AMD) Market
8.4.4.5.1 South Africa Age Related Macular Degeneration (AMD) Market by Drug Type
8.4.4.5.2 South Africa Age Related Macular Degeneration (AMD) Market by Disease Type
8.4.4.5.3 South Africa Age Related Macular Degeneration (AMD) Market by Distribution Channel
8.4.4.6 Nigeria Age Related Macular Degeneration (AMD) Market
8.4.4.6.1 Nigeria Age Related Macular Degeneration (AMD) Market by Drug Type
8.4.4.6.2 Nigeria Age Related Macular Degeneration (AMD) Market by Disease Type
8.4.4.6.3 Nigeria Age Related Macular Degeneration (AMD) Market by Distribution Channel
8.4.4.7 Rest of LAMEA Age Related Macular Degeneration (AMD) Market
8.4.4.7.1 Rest of LAMEA Age Related Macular Degeneration (AMD) Market by Drug Type
8.4.4.7.2 Rest of LAMEA Age Related Macular Degeneration (AMD) Market by Disease Type
8.4.4.7.3 Rest of LAMEA Age Related Macular Degeneration (AMD) Market by Distribution Channel

Chapter 9. Company Profiles
9.1 Biogen, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.6 SWOT Analysis
9.2 Bayer AG
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 SWOT Analysis
9.3 Apellis Pharmaceuticals, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Approvals & Trails:
9.3.6 SWOT Analysis
9.4 Regeneron Pharmaceuticals, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Research & Development Expense
9.4.4 SWOT Analysis
9.5 F. Hoffmann-La Roche Ltd.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 SWOT Analysis
9.6 Ionis Pharmaceuticals, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Research & Development Expenses
9.6.4 SWOT Analysis
9.7 Novartis AG
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Approvals & Trails:
9.7.5.2 Acquisition and Mergers:
9.7.6 SWOT Analysis
9.8 Sanofi S.A.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 SWOT Analysis
9.9 Coherus Biosciences, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Research & Development Expenses
9.9.4 Recent strategies and developments:
9.9.4.1 Approvals & Trials:
9.9.5 SWOT Analysis
9.1 Bausch Health Companies, Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expense
9.10.5 Recent strategies and developments:
9.10.5.1 Product Launches and Product Expansions:
9.10.6 SWOT Analysis
Chapter 10. Winning Imperative for Age Related Macular Degeneration (AMD) Market

TABLE 1 Global Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 2 Global Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 3 Global Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 4 Global Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 5 Global Aflibercept Market by Region, 2019 - 2022, USD Million
TABLE 6 Global Aflibercept Market by Region, 2023 - 2030, USD Million
TABLE 7 Global Ranibizumab Market by Region, 2019 - 2022, USD Million
TABLE 8 Global Ranibizumab Market by Region, 2023 - 2030, USD Million
TABLE 9 Global Others Market by Region, 2019 - 2022, USD Million
TABLE 10 Global Others Market by Region, 2023 - 2030, USD Million
TABLE 11 Global Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 12 Global Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 13 Global Wet Market by Region, 2019 - 2022, USD Million
TABLE 14 Global Wet Market by Region, 2023 - 2030, USD Million
TABLE 15 Global Dry Market by Region, 2019 - 2022, USD Million
TABLE 16 Global Dry Market by Region, 2023 - 2030, USD Million
TABLE 17 Global Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 18 Global Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 19 Global Hospital Pharmacy Market by Region, 2019 - 2022, USD Million
TABLE 20 Global Hospital Pharmacy Market by Region, 2023 - 2030, USD Million
TABLE 21 Global Retail Pharmacy Market by Region, 2019 - 2022, USD Million
TABLE 22 Global Retail Pharmacy Market by Region, 2023 - 2030, USD Million
TABLE 23 Global Online Pharmacy Market by Region, 2019 - 2022, USD Million
TABLE 24 Global Online Pharmacy Market by Region, 2023 - 2030, USD Million
TABLE 25 Global Age Related Macular Degeneration (AMD) Market by Region, 2019 - 2022, USD Million
TABLE 26 Global Age Related Macular Degeneration (AMD) Market by Region, 2023 - 2030, USD Million
TABLE 27 North America Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 28 North America Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 29 North America Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 30 North America Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 31 North America Aflibercept Market by Country, 2019 - 2022, USD Million
TABLE 32 North America Aflibercept Market by Country, 2023 - 2030, USD Million
TABLE 33 North America Ranibizumab Market by Country, 2019 - 2022, USD Million
TABLE 34 North America Ranibizumab Market by Country, 2023 - 2030, USD Million
TABLE 35 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 36 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 37 North America Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 38 North America Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 39 North America Wet Market by Country, 2019 - 2022, USD Million
TABLE 40 North America Wet Market by Country, 2023 - 2030, USD Million
TABLE 41 North America Dry Market by Country, 2019 - 2022, USD Million
TABLE 42 North America Dry Market by Country, 2023 - 2030, USD Million
TABLE 43 North America Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 44 North America Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 45 North America Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 46 North America Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 47 North America Retail Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 48 North America Retail Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 49 North America Online Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 50 North America Online Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 51 North America Age Related Macular Degeneration (AMD) Market by Country, 2019 - 2022, USD Million
TABLE 52 North America Age Related Macular Degeneration (AMD) Market by Country, 2023 - 2030, USD Million
TABLE 53 US Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 54 US Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 55 US Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 56 US Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 57 US Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 58 US Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 59 US Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 60 US Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 61 Canada Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 62 Canada Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 63 Canada Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 64 Canada Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 65 Canada Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 66 Canada Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 67 Canada Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 68 Canada Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 69 Mexico Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 70 Mexico Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 71 Mexico Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 72 Mexico Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 73 Mexico Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 74 Mexico Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 75 Mexico Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 76 Mexico Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 77 Rest of North America Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 78 Rest of North America Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 79 Rest of North America Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 80 Rest of North America Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 81 Rest of North America Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 82 Rest of North America Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 83 Rest of North America Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 84 Rest of North America Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 85 Europe Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 86 Europe Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 87 Europe Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 88 Europe Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 89 Europe Aflibercept Market by Country, 2019 - 2022, USD Million
TABLE 90 Europe Aflibercept Market by Country, 2023 - 2030, USD Million
TABLE 91 Europe Ranibizumab Market by Country, 2019 - 2022, USD Million
TABLE 92 Europe Ranibizumab Market by Country, 2023 - 2030, USD Million
TABLE 93 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 94 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 95 Europe Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 96 Europe Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 97 Europe Wet Market by Country, 2019 - 2022, USD Million
TABLE 98 Europe Wet Market by Country, 2023 - 2030, USD Million
TABLE 99 Europe Dry Market by Country, 2019 - 2022, USD Million
TABLE 100 Europe Dry Market by Country, 2023 - 2030, USD Million
TABLE 101 Europe Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 102 Europe Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 103 Europe Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 104 Europe Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 105 Europe Retail Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 106 Europe Retail Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 107 Europe Online Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 108 Europe Online Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 109 Europe Age Related Macular Degeneration (AMD) Market by Country, 2019 - 2022, USD Million
TABLE 110 Europe Age Related Macular Degeneration (AMD) Market by Country, 2023 - 2030, USD Million
TABLE 111 Germany Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 112 Germany Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 113 Germany Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 114 Germany Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 115 Germany Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 116 Germany Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 117 Germany Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 118 Germany Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 119 UK Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 120 UK Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 121 UK Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 122 UK Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 123 UK Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 124 UK Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 125 UK Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 126 UK Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 127 France Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 128 France Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 129 France Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 130 France Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 131 France Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 132 France Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 133 France Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 134 France Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 135 Russia Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 136 Russia Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 137 Russia Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 138 Russia Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 139 Russia Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 140 Russia Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 141 Russia Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 142 Russia Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 143 Spain Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 144 Spain Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 145 Spain Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 146 Spain Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 147 Spain Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 148 Spain Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 149 Spain Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 150 Spain Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 151 Italy Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 152 Italy Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 153 Italy Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 154 Italy Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 155 Italy Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 156 Italy Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 157 Italy Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 158 Italy Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 159 Rest of Europe Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 160 Rest of Europe Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 161 Rest of Europe Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 162 Rest of Europe Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 163 Rest of Europe Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 164 Rest of Europe Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 165 Rest of Europe Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 166 Rest of Europe Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 167 Asia Pacific Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 168 Asia Pacific Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 169 Asia Pacific Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 170 Asia Pacific Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 171 Asia Pacific Aflibercept Market by Country, 2019 - 2022, USD Million
TABLE 172 Asia Pacific Aflibercept Market by Country, 2023 - 2030, USD Million
TABLE 173 Asia Pacific Ranibizumab Market by Country, 2019 - 2022, USD Million
TABLE 174 Asia Pacific Ranibizumab Market by Country, 2023 - 2030, USD Million
TABLE 175 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 176 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 177 Asia Pacific Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 178 Asia Pacific Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 179 Asia Pacific Wet Market by Country, 2019 - 2022, USD Million
TABLE 180 Asia Pacific Wet Market by Country, 2023 - 2030, USD Million
TABLE 181 Asia Pacific Dry Market by Country, 2019 - 2022, USD Million
TABLE 182 Asia Pacific Dry Market by Country, 2023 - 2030, USD Million
TABLE 183 Asia Pacific Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 184 Asia Pacific Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 185 Asia Pacific Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 186 Asia Pacific Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 187 Asia Pacific Retail Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 188 Asia Pacific Retail Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 189 Asia Pacific Online Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 190 Asia Pacific Online Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 191 Asia Pacific Age Related Macular Degeneration (AMD) Market by Country, 2019 - 2022, USD Million
TABLE 192 Asia Pacific Age Related Macular Degeneration (AMD) Market by Country, 2023 - 2030, USD Million
TABLE 193 China Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 194 China Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 195 China Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 196 China Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 197 China Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 198 China Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 199 China Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 200 China Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 201 Japan Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 202 Japan Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 203 Japan Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 204 Japan Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 205 Japan Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 206 Japan Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 207 Japan Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 208 Japan Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 209 India Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 210 India Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 211 India Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 212 India Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 213 India Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 214 India Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 215 India Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 216 India Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 217 South Korea Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 218 South Korea Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 219 South Korea Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 220 South Korea Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 221 South Korea Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 222 South Korea Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 223 South Korea Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 224 South Korea Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 225 Singapore Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 226 Singapore Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 227 Singapore Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 228 Singapore Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 229 Singapore Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 230 Singapore Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 231 Singapore Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 232 Singapore Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 233 Malaysia Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 234 Malaysia Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 235 Malaysia Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 236 Malaysia Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 237 Malaysia Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 238 Malaysia Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 239 Malaysia Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 240 Malaysia Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 241 Rest of Asia Pacific Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 242 Rest of Asia Pacific Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 243 Rest of Asia Pacific Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 244 Rest of Asia Pacific Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 245 Rest of Asia Pacific Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 246 Rest of Asia Pacific Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 247 Rest of Asia Pacific Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 248 Rest of Asia Pacific Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 249 LAMEA Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 250 LAMEA Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 251 LAMEA Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 252 LAMEA Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 253 LAMEA Aflibercept Market by Country, 2019 - 2022, USD Million
TABLE 254 LAMEA Aflibercept Market by Country, 2023 - 2030, USD Million
TABLE 255 LAMEA Ranibizumab Market by Country, 2019 - 2022, USD Million
TABLE 256 LAMEA Ranibizumab Market by Country, 2023 - 2030, USD Million
TABLE 257 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 258 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 259 LAMEA Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 260 LAMEA Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 261 LAMEA Wet Market by Country, 2019 - 2022, USD Million
TABLE 262 LAMEA Wet Market by Country, 2023 - 2030, USD Million
TABLE 263 LAMEA Dry Market by Country, 2019 - 2022, USD Million
TABLE 264 LAMEA Dry Market by Country, 2023 - 2030, USD Million
TABLE 265 LAMEA Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 266 LAMEA Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 267 LAMEA Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 268 LAMEA Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 269 LAMEA Retail Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 270 LAMEA Retail Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 271 LAMEA Online Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 272 LAMEA Online Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 273 LAMEA Age Related Macular Degeneration (AMD) Market by Country, 2019 - 2022, USD Million
TABLE 274 LAMEA Age Related Macular Degeneration (AMD) Market by Country, 2023 - 2030, USD Million
TABLE 275 Brazil Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 276 Brazil Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 277 Brazil Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 278 Brazil Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 279 Brazil Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 280 Brazil Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 281 Brazil Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 282 Brazil Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 283 Argentina Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 284 Argentina Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 285 Argentina Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 286 Argentina Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 287 Argentina Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 288 Argentina Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 289 Argentina Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 290 Argentina Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 291 UAE Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 292 UAE Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 293 UAE Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 294 UAE Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 295 UAE Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 296 UAE Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 297 UAE Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 298 UAE Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 299 Saudi Arabia Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 300 Saudi Arabia Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 301 Saudi Arabia Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 302 Saudi Arabia Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 303 Saudi Arabia Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 304 Saudi Arabia Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 305 Saudi Arabia Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 306 Saudi Arabia Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 307 South Africa Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 308 South Africa Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 309 South Africa Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 310 South Africa Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 311 South Africa Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 312 South Africa Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 313 South Africa Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 314 South Africa Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 315 Nigeria Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 316 Nigeria Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 317 Nigeria Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 318 Nigeria Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 319 Nigeria Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 320 Nigeria Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 321 Nigeria Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 322 Nigeria Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 323 Rest of LAMEA Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 324 Rest of LAMEA Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 325 Rest of LAMEA Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 326 Rest of LAMEA Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 327 Rest of LAMEA Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 328 Rest of LAMEA Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 329 Rest of LAMEA Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 330 Rest of LAMEA Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 331 Key Information – Biogen, Inc.
TABLE 332 Key Information – Bayer AG
TABLE 333 Key Information – Apellis Pharmaceuticals, Inc.
TABLE 334 Key Information – Regeneron Pharmaceuticals, Inc.
TABLE 335 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 336 Key information – Ionis Pharmaceuticals, Inc.
TABLE 337 Key Information – Novartis AG
TABLE 338 Key Information – Sanofi S.A.
TABLE 339 Key Information – Coherus Biosciences, Inc.
TABLE 340 key information – Bausch Health Companies, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Global Age Related Macular Degeneration (AMD) Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Age Related Macular Degeneration (AMD)Market
FIG 4 Porter’s Five Forces Analysis – Age Related Macular Degeneration (AMD) Market
FIG 5 Global Age Related Macular Degeneration (AMD) Market share by Drug Type, 2022
FIG 6 Global Age Related Macular Degeneration (AMD) Market share by Drug Type, 2030
FIG 7 Global Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2030, USD Million
FIG 8 Global Age Related Macular Degeneration (AMD) Market share by Disease Type, 2022
FIG 9 Global Age Related Macular Degeneration (AMD) Market share by Disease Type, 2030
FIG 10 Global Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2030, USD Million
FIG 11 Global Age Related Macular Degeneration (AMD) Market share by Distribution Channel, 2022
FIG 12 Global Age Related Macular Degeneration (AMD) Market share by Distribution Channel, 2030
FIG 13 Global Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2030, USD Million
FIG 14 Global Age Related Macular Degeneration (AMD) Market share by Region, 2022
FIG 15 Global Age Related Macular Degeneration (AMD) Market share by Region, 2030
FIG 16 Global Age Related Macular Degeneration (AMD) Market by Region, 2019 - 2030, USD Million
FIG 17 Swot Analysis: Biogen, Inc.
FIG 18 Swot Analysis: Bayer AG
FIG 19 Swot Analysis: Apellis Pharmaceuticals, Inc.
FIG 20 Swot Analysis: Regeneron Pharmaceuticals, Inc.
FIG 21 Swot Analysis: F. Hoffmann-La Roche Ltd.
FIG 22 Swot Analysis: Ionis Pharmaceuticals, Inc.
FIG 23 SWOT Analysis: Novartis AG
FIG 24 Swot Analysis: Sanofi S.A.
FIG 25 Swot Analysis: Coherus Biosciences, Inc.
FIG 26 Swot Analysis: Bausch Health Companies, Inc.